-
South Korea captain 'deeply sorry' for gloating about military exemption
-
Germany's Merz in Kyiv for talks with Zelensky
-
Alcaraz through to Japan Open semis after Shapovalov injury
-
Asian Games set to close after records, rancour and rain
-
Chanel: unpicking one year of 'Blazymania'
-
Cry for help as French-Swiss lake dries up
-
Latvian pro-Europeans set for election win: partial results
-
Sabalenka swept out of China Open in third round
-
China swim sensation Yu Zidi, 13, says 'I'm no prodigy'
-
US urges 'restraint' as Ethiopia's Tigray crisis rocks region
-
Yu Zidi to Ohashi: Asian Games stars who can light up LA Olympics
-
Teens on target again as USA down Mexico 3-0
-
'Act before it's too late': Tokyo residents fight for more trees
-
World records prove Asian Games were a hit, says top official
-
'Disappointing' as South Korea flag mishap sees Games end on sour note
-
US prison chief who oversaw botched execution resigns
-
Pre-COP host Tuvalu at frontline of climate change
-
'Chaotic' Asian Games threaten Japan hopes of hosting Olympics again
-
Hungary's dwindling paprika producers battle to save signature spice
-
Finnish town braces for change from Google data centres
-
Cornell president vows review in wake of alleged student gang rape
-
What is fuelling French school protests?
-
Latvian partial election results suggest pro-European choice
-
Without lawyers, migrant children face deportation from the US
-
In Egypt's Sinai, Gazan builds school for children displaced by war
-
Three-peat seeking Dodgers open playoffs with a win, Rays hold off Yankees
-
Trump tariffs a mixed bag for US auto industry
-
Brazil votes in nail-biter polls closely watched by Trump
-
Yemen government forces say struck Houthi targets
-
'Just be you': Kim reveals Tiger text that inspired him to gold
-
Music links past, present for Pedro Pascal's cellist in 'Behemoth!'
-
Myanmar migrants returned to war-torn nation from Malaysia
-
ALEX BODI ȘI AMBASADORUL REPUBLICII SUDANUL DE SUD, GUM DOMINIC MATIOK, DISCUTĂ LA BERLIN DESPRE POSIBILITATEA ÎNFIINȚĂRII UNUI CONSULAT ONORIFIC LA BUCUREȘTI
-
ALEX BODI AND AMBASSADOR GUM DOMINIC MATIOK OF THE REPUBLIC OF SOUTH SUDAN MEET IN BERLIN TO DISCUSS THE POSSIBILITY OF AN HONORARY CONSULATE IN BUCHAREST
-
Dodgers step up World Series three-peat bid with 5-3 win over Braves
-
Lula, Bolsonaro wrap up campaigns ahead of Brazil's knife-edge vote
-
Spain break down Czechs as England outclass Croatia in Nations League
-
Toulouse edge Castres in Top 14 derby
-
Yamal on target as Spain hold off Czech Republic
-
Murakami homer propels White Sox to MLB playoff win over Guardians
-
Latvian exit polls suggest pro-European choice
-
Israel targets top Hamas leader in deadly Gaza strike on anniversary
-
Lula, Bolsonaro wrap up campaigns ahead of knife-edge election
-
Houthis say struck oil facility near Riyadh, as Saudis hit Sanaa
-
Tuchel hails 'complete' England after Croatia demolition
-
AI needs safety layers like nuclear plants: ex-OpenAI engineer
-
Fury to invite Trump to lead ring walk before Joshua showdown
-
MVP Judge will miss Yankees' MLB playoff series against Rays
-
Fashion industry in 'precarious moment', says Vivienne Westwood supremo
-
New lizard species discovered in Peru
First Covid vaccine side-effect claims land in German courts
Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.
In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.
But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.
In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.
The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.
In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.
She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.
Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.
He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.
- 'Rocky and long road' -
BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.
Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.
With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.
But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.
Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.
Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.
He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.
- 'Not an isolated case' -
A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".
In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.
A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.
She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.
"I hate it when people tell me that I'm an isolated case," she said. "I'm not."
To address the question of causality, the courts would likely have to obtain expert advice.
Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.
More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.
BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.
"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.
Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.
"I hope that people with post-vaccination syndromes can be taken seriously," she said.
C.Kovalenko--BTB